Phase I/II Randomized Trial of Sorafenib and Bevacizumab as First-Line Therapy in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: North Central Cancer Treatment Group Trial N0745 (Alliance)
Titel:
Phase I/II Randomized Trial of Sorafenib and Bevacizumab as First-Line Therapy in Patients with Locally Advanced or Metastatic Hepatocellular Carcinoma: North Central Cancer Treatment Group Trial N0745 (Alliance)
Auteur:
Hubbard, Joleen M. Mahoney, Michelle R. Loui, William S. Roberts, Lewis R. Smyrk, Thomas C. Gatalica, Zoran Borad, Mitesh Kumar, Shaji Alberts, Steven R.